EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Advancing FIRES Treatment: The Potential of Intrathecal Dexamethasone

Carol Park, Douglas R Nordli, Mohamed Taha, Henry David, Shawn Kacker, Tareq Kass-Hout, Sonam Thind, Aurelie Hanin, Sana Said, Hiba A Haider, Douglas R Nordli

Annals of the Child Neurology Society · 2025-06 · 3 (2) · 115-120

DOI: 10.1002/cns3.70008 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Annals of the Child Neurology Society, online erschienen am 11.05.2025. Verfasst von Carol Park und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatric Neurology, Comer Children's Hospital University of Chicago Chicago Illinois USA. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Febrile infection‐related epilepsy syndrome (FIRES) is a rare, devastating epilepsy syndrome characterized by refractory status epilepticus following a febrile illness. Patient Description We describe a 12‐year‐old girl with FIRES who exhibited a remarkable clinical and electrographic response to intrathecal dexamethasone (IT‐DEX) after failing multiple antiseizure and immunomodulatory therapies. Despite persistent neuroinflammation, IT‐DEX led to rapid seizure control and significant neurological recovery.

Conclusion

This report supports IT‐DEX as a promising intervention in FIRES and underscores the need for further research into its mechanisms and long‐term efficacy.

Schlagwörter

Stichwörter der Autor:innen

FIRESNORSEstatus epilepticus

Autor:innen und Institutionen

  • Department of Pediatric Neurology, Comer Children's Hospital University of Chicago Chicago Illinois USA.
  • Advocate Children's Medical Group Park Ridge Illinois USA.
  • Department of Neurology University of Chicago Chicago Illinois USA.
  • Department of Neurology, Comprehensive Epilepsy Center Yale University School of Medicine New Haven Connecticut USA.
  • Department of Pharmacy University of Chicago Chicago Illinois USA.

Zitieren

APA

Park, C., Nordli, D. R., Taha, M., David, H., Kacker, S., Kass-Hout, T., Thind, S., Hanin, A., Said, S., Haider, H. A., & Nordli, D. R. (2025). Advancing FIRES Treatment: The Potential of Intrathecal Dexamethasone. Annals of the Child Neurology Society, 3(2), 115-120. https://doi.org/10.1002/cns3.70008

Vancouver

Park C, Nordli DR, Taha M, David H, Kacker S, Kass-Hout T, et al. Advancing FIRES Treatment: The Potential of Intrathecal Dexamethasone. Annals of the Child Neurology Society. 2025;3(2):115-120. doi:10.1002/cns3.70008

BibTeX
@article{Park2025,
  author = {Park, Carol and Nordli, Douglas R and Taha, Mohamed and David, Henry and Kacker, Shawn and Kass-Hout, Tareq and Thind, Sonam and Hanin, Aurelie and Said, Sana and Haider, Hiba A and Nordli, Douglas R},
  title = {Advancing FIRES Treatment: The Potential of Intrathecal Dexamethasone},
  journal = {Annals of the Child Neurology Society},
  year = {2025},
  volume = {3},
  number = {2},
  pages = {115--120},
  doi = {10.1002/cns3.70008}
}
Kostenlos starten →